Form 8-K - Current report:
SEC Accession No. 0001387131-20-002363
Filing Date
2020-02-28
Accepted
2020-02-28 17:17:23
Documents
5
Period of Report
2020-02-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp-8k_022820.htm 8-K 41345
2 OPINION OF BROWNSTEIN HYATT FARBER SCHRECK, LLP ex5-01.htm EX-5.01 12668
3 PLACEMENT AGENCY AGREEMENT ex10-01.htm EX-10.01 51793
4 FORM OF SECURITIES PURCHASE AGREEMENT ex10-02.htm EX-10.02 208982
5 PRESS RELEASE ex99-01.htm EX-99.01 14470
  Complete submission text file 0001387131-20-002363.txt   330579
Mailing Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1220
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 20672266
SIC: 2834 Pharmaceutical Preparations